The tweet was deleted by the author.
But we saved everything 🙂.
Vir Biotechnology is commemorating its tenth anniversary, reflecting on a decade marked by growth, innovation and transformation.
The company credits its commitment to scientific rigor as a foundation that has remained unchanged since its early days, as noted by one of its first employees, Cara Pilowa. Over the past 10 years, Vir Biotechnology has relied on its people and their dedication to shaping the organization’s journey. Details on future initiatives or product developments have not been disclosed. Details are being clarified.
View post on X Loading...
Earlier this year, Vir Biotechnology outlined a timeline marking key scientific advances and organizational milestones over the past decade in a company feature. In its most recent quarterly update, Vir Biotechnology reported over $1.0 billion in cash while advancing its CHD and oncology programs, according to company filings. The firm’s financial and research progress continues to shape its long-term strategy.